Comment from the Editor-in-Chief {#rrw125s1}
================================

The Board of Editors of the *Journal of Radiation Research* is pleased to announce that Dr Yoshitaka Matsumoto and co-authors are the winners of the 2016 Terasima Award, given for their outstanding paper published in the *Journal of Radiation Research* in 2014 and 2015. In 2001, the *Journal of Radiation Research* established the Terasima Award honoring Dr Toyozo Terasima, a pioneer in Japan in the field of radiation research. Since then it has been awarded annually to the authors of the journal\'s most prominent paper published in each year. In 2016, three papers were nominated for the Award, and the paper by Dr Y. Matsumoto *et al*. received the highest evaluation. He and his co-authors received a certificate, a 100 000 yen award, and exemption from processing charges on their next article published in the *Journal of Radiation Research*.

Comment from the Author {#rrw125s2}
=======================

I have been given the opportunity to receive a wonderful prize---the *Journal of Radiation Research* Terasima Award---for our paper "Enhanced radiobiological effects at the distal end of a clinical proton beam: *in vitro* study" published in *Journal of Radiation Research*. Professor Toyozo Terasima discovered the cell cycle dependence of radiosensitivity in 1961, and his achievement has been highly regarded internationally. He also served as the fifth director of the National Institute of Radiological Sciences (NIRS) (to which I belonged), and he is one of my most respected researchers---I have heard his name since I was a student. I received the award that was given the great teacher\'s name, and I would like to thank Professor Furusawa at NIRS, Professor Ando at Gunma University, and Professors Sakurai and Tsuboi at the University of Tsukuba for their leading and advise.

In this paper, we aimed to examine the validity of the uniform relative biological effectiveness (RBE) value of a proton beam (1.1), clinically used as an international standard. In our previous report, the RBE of the clinical proton beam at six proton beam treatment facilities in Japan was reported to be 1.05 (on average) at the center of the spread-out Bragg peak (SOBP), and there was no significant difference from the international standard value of 1.1. In this research, however, the RBE of the proton beam increased, depending on the depth, yielding a value of 1.5--1.7 at the distal-end region of the SOBP. A high RBE in the distal-end region led to an extension of the uniform biological dose region, and an extension of 3.6--4.1 mm was observed in this experiment.

Proton therapy facilities are increasing, not only in Japan but also globally, and it is important to establish therapeutic methods that take biological characteristics into consideration for safer and more efficient treatments. Because of this, many researchers are interested in our research. We are grateful for their numerous citations of our paper, and I am keen to continue our research and to contribute to the improvement of radiotherapy.
